Financial News
Articles published by Ligand Pharmaceuticals Incorporated
![](https://mms.businesswire.com/media/20230725467229/en/346436/5/Ligand-Logo-Registered5.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230717515826/en/346436/5/Ligand-Logo-Registered5.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230516005532/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20230504006023/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20230424005882/en/346436/5/Ligand-Logo-Registered5.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230222005940/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230217005377/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20230206005621/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand to Report Fourth Quarter Financial Results on February 22
February 06, 2023
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20230106005095/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20221205005272/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Pharmaceuticals Names Director Todd C. Davis as CEO
December 05, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20221116005413/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand to Hold Investor and Analyst Day on December 13
November 16, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20221107006075/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Reports Third Quarter 2022 Financial Results
November 07, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20221101006208/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20221101005642/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Distribution of OmniAb Complete and Business Combination Closed
November 01, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20221026005643/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand to Report Third Quarter Financial Results on November 7
October 26, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20221026005412/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20221024005850/en/346436/5/Ligand-Logo-Registered5.jpg)
OmniAb Business Combination Approved by APAC Shareholders
October 24, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221003006023/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20221003005364/en/346436/5/Ligand-Logo-Registered5.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20220824005738/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20220808005723/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Reports Second Quarter 2022 Financial Results
August 08, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220801005841/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 01, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20220722005458/en/346436/5/Ligand-Logo-Registered5.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20220629005848/en/346436/5/Ligand-Logo-Registered5.jpg)
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20220504006080/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Reports First Quarter 2022 Financial Results
May 04, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220419005883/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand to Report First Quarter Financial Results on May 4
April 19, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20220408005582/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 08, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20220323005896/en/1399331/5/AvistaLogo_Original_WithWhiteBackground.jpg)
![](https://mms.businesswire.com/media/20220217005827/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
February 17, 2022
Via Business Wire
Tickers
LGND
![](https://mms.businesswire.com/media/20220209005338/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand to Report Fourth Quarter Financial Results on February 17
February 09, 2022
Via Business Wire
Tickers
LGND
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.